- Home
- MNPR vs TACO Comparison
MNPR vs TACO Comparison
Compare MNPR & TACO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$62.74
Company Overview
Basic Information| Metric | MNPR | TACO |
|---|---|---|
| Founded | 2014 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.9M | 391.7M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | MNPR | TACO |
|---|---|---|
| Price | $62.74 | $10.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $107.00 | N/A |
| AVG Volume (30 Days) | ★ 164.9K | 122.0K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.99 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.40 | $10.11 |
| 52 Week High | $105.00 | $10.85 |
Technical Indicators
Market Signals| Indicator | MNPR | TACO |
|---|---|---|
| Relative Strength Index (RSI) | 56.98 | 82.18 |
| Support Level | $51.71 | $10.42 |
| Resistance Level | $67.90 | $10.50 |
| Average True Range (ATR) | 5.65 | 0.03 |
| MACD | 0.27 | 0.00 |
| Stochastic Oscillator | 68.24 | 48.15 |
Price Performance
Historical Comparison MNPR
TACO
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About TACO Berto Acquisition Corp. Ordinary Shares
Berto Acquisition Corp is a blank check company.